Bayer CEO Doesn’t See Job Cuts as Answer to a Potential Problem

The transcript discusses Bayer's financial performance, job cuts, and strategic adjustments following the Monsanto transaction. It highlights the company's strong results and positive outlook for 2019, despite market volatility. The discussion also covers the impact of German employment laws on job cuts and addresses concerns from activist investors about the company's strategy.

What was the main reason for Bayer's positive outlook for 2019?

• Increased demand for their products

• A successful merger with another company

• A decrease in market volatility

• Strong financial results and structural measures

How many employees does Bayer plan to reduce over the next four years?

• 18,000

• 15,000

• 12,000

• 10,000

What is one advantage of the European model in handling job cuts according to the transcript?

• Better care for employees

• Faster implementation

• Higher efficiency

• Lower costs

What major change has Bayer undergone in recent years?

• Becoming a leading technology company

• Refocusing as a premier life sciences company

• Expanding into new geographical markets

• Diversifying into unrelated industries

What is the purpose of Bayer's right-sizing strategy?

• To comply with new regulations

• To focus on a single product line

• To become more competitive and support growth

• To reduce costs significantly

What was the activist investor's suggestion to Bayer?

• To increase their workforce

• To focus solely on pharmaceuticals

• To break up into agrochemicals and pharmaceuticals

• To merge with another company

How does Bayer view its growth prospects according to the transcript?

• Dependent on external factors

• Uncertain due to market conditions

• Limited to certain regions

• Promising with increasing profitability